GL1X · GenesisL1 explorer

Research workbench

GC1 beta-lactamase with a penem inhibitor

Analyse GC1 beta-lactamase with a penem inhibitor in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1ONH
Type
protein
Length
363 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Class C beta-lactamase
EC
3.5.2.6
UniProt
Q59401
Ligands
WY4
Pockets
1 · best druggability 0.74

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AClass C beta-lactamase (EC 3.5.2.6)protein36340% helix, 23% strandQ59401

Ligands and binding sites

  • WY4 · 7-(5,6-dihydro-8H-imidazo[2,1-c][1,4]oxazin-2-yl)-6-formyl-2,7-dihydro- [1,4]thiazepine-3-carboxylic acid · ligand · chains A
  • GOL · Glycerol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16020.740.8172WY4, GOL

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 1ONH · GC1 beta-lactamase with a penem inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.